| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChemCID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C16H23N3 |
| Molar mass | 257.381 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
E-55888 is a drug developed by Esteve, which acts as a potent and selective full agonist at the 5HT7serotoninreceptor, and is used for investigating the role of 5-HT7 receptors in the perception of pain. When administered by itself, E-55888 is anti-hyperalgesic but not analgesic, but when administered alongside morphine, E-55888 was found to significantly increase the analgesic effects.[1][2]